10.1002/anie.201906001
Angewandte Chemie International Edition
RESEARCH ARTICLE
Formation of iodonitrene:[14]
[1]
a) F. W. Goldberg, J. G. Kettle, T. Kogej, M. W. D. Perry, N. P.
Tomkinson, Drug Discov. Today 2015, 20, 11; b) C. W. Murray, D. C.
Rees, Angew. Chem. Int. Ed. 2016, 55, 488; Angew. Chem. 2016, 128,
498; c) J. A. Bull, R. A. Croft, O. A. Davis, R. Doran, K. F. Morgan, Chem.
Rev. 2016, 116, 12150; Also see: d) D. C. Blakemore, L. Castro, I.
Churcher, D. C. Rees, A. W. Thomas, D. M. Wilson, A. Wood, Nat. Chem.
2018, 10, 383; e) A. Nadin, C. Hattotuwagama, I. Churcher, Angew.
Chem. Int. Ed. 2012, 51, 1114; Angew. Chem. 2012, 124, 1140.
a) C. Gnamm, A. Jeanguenat, A. C. Dutton, C. Grimm, D. P. Kloer, A. J.
Crossthwaite, Bioorg. Med. Chem. Lett. 2012, 22, 3800; b) P. K.
Chinthakindi, T. Naicker, N. Thota, T. Govender, H. G. Kruger, P. I.
Arvidsson, Angew. Chem. Int. Ed. 2017, 56, 4100; Angew. Chem. 2017,
129, 4160; c) U. Lücking, Angew. Chem. Int. Ed. 2013, 52, 9399; Angew.
Chem. 2013, 125, 9570; d) M. Frings, C. Bolm, A. Blum, C. Gnamm, Eur.
J. Med. Chem. 2017, 126, 225; e) F. Sehgelmeble, J. Janson, C. Ray, S.
Rosqvist, S. Gustavsson, L. I. Nilsson, A. Minidis, J. Holenz, D. Rotticci,
J. Lundkvist, et al., ChemMedChem 2012, 7, 396; f) S. R. Borhade, R.
Svensson, P. Brandt, P. Artursson, P. I. Arvidsson, A. Sandström,
ChemMedChem 2015, 10, 455; g) J. A. Bull, L. Degennaro, R. Luisi,
Synlett 2017, 28, 2525; h) U. Lücking, Org. Chem. Front. 2019, 6, 1319.
For sulfonimidamides as coordinating groups and ligands, see: a) J.
Buendia, G. Grelier, B. Darses, A. G. Jarvis, F. Taran, P. Dauban, Angew.
Chem. Int. Ed. 2016, 55, 7530; Angew. Chem. 2016, 128, 7656; b) J.
Buendia, B. Darses, P. Dauban, Angew. Chem. Int. Ed. 2015, 54, 5697;
Angew. Chem. 2015, 127, 5789; c) M. Steurer, C. Bolm, J. Org. Chem.
2010, 75, 3301; d) C. Worch, C. Bolm, Synlett 2009, 2009, 2425.
a) U. Lücking, R. Jautelat, M. Krüger, T. Brumby, P. Lienau, M. Schäfer,
H. Briem, J. Schulze, A. Hillisch, A. Reichel, et al., ChemMedChem 2013,
8, 1067; b) U. Lücking, A. Scholz, P. Lienau, G. Siemeister, D. Kosemund,
R. Bohlmann, H. Briem, I. Terebesi, K. Meyer, K. Prelle, et al.,
ChemMedChem 2017, 12, 1776.
[O]
iPrOH
NH3
PhIO
PhI(OiPr)2
PhI=NH
Ph
I N
-H2O
-iPrOH
Formation of sulfonimidamides:
R
O
S
N
R
OH
N
RCO H
P
P
2
ArSH
ArOH
IPh
[2]
Ph
I
N
N
S
AcO
HO
N
P
O
O
AcOH
or
AcO
S
S
N
N
N
ROH
AcO
H2O
ROH
P
P
N
O
S
NH
H2O
S
N
N
Scheme 8. Proposed mechanism of sulfonimidamide formation.
[3]
Conclusion
In summary, we have developed an efficient method for the
preparation of NH-sulfonimidamides from sulfenamides. A highly
selective one-pot NH and O transfer is achieved, using a simple
ammonia source and a hypervalent iodine reagent. The use of
iodosylbenzene allows for control over the acidity of the reaction,
with one equivalent of acetic acid optimal for formation of the
desired sulfonimidamide. In the absence of added acid, an
unprecedented alkoxy-amino-l6-sulfanenitrile is isolated as a
reaction intermediate. The isolation and characterization of
several examples of this novel species provides insight into the
reaction mechanism, and identifies the solvent as one source of
the oxygen atom in the product. These newly formed alkoxy-
amino-l6-sulfanenitriles act as alkylating agents to a range of
acidic nucleophiles. Other pathways through the addition of water
or acetate are also operative. The sulfenamide to
sulfonimidamide transformation is tolerant of a range of functional
[4]
[5]
a) K. M. Foote, J. W. M. Nissink, T. McGuire, P. Turner, S. Guichard, J.
W. T. Yates, A. Lau, K. Blades, D. Heathcote, R. Odedra, et al., J. Med.
Chem. 2018, 61, 9889; b) F. P. Vendetti, A. Lau, S. Schamus, T. P.
Conrads, M. J. O’Connor, C. J. Bakkenist, Oncotarget 2015, 6, 44289.
T. Q. Davies, A. Hall, M. C. Willis, Angew. Chem. Int. Ed. 2017, 56,
14937; Angew. Chem. 2017, 129, 15133.
[6]
[7]
[8]
A. D. Steinkamp, L. Schmitt, X. Chen, K. Fietkau, R. Heise, J. M. Baron,
C. Bolm, Skin Pharmacol. Physiol. 2017, 29, 281.
S. Chowdhury, C. M. Dehnhardt, T. Focken, M. E. Grimwood, I. W.
Hemeon, S. McKerrall, D. Sutherlin (Genentech, Inc.), WO 2017172802,
2017.
groups, displaying
a wide substrate scope, including the
[9]
For a review: G. C. Nandi, P. I. Arvidsson, Adv. Synth. Catal. 2018, 360,
2976.
functionalization of anti-depressants desipramine and fluoxetine.
The method was used in the synthesis of an aza-analogue of the
sulfonamide drug probenecid, as well as displaying possible
useful N-functionalization reactions on this scaffold,
demonstrating the utility of the methodology for medicinal
chemistry.
[10] B. Gao, S. Li, P. Wu, J. E. Moses, K. B. Sharpless, Angew. Chem. Int.
Ed. 2018, 57, 1939; Angew. Chem. 2018; 130, 1957.
[11] H. Yu, Z. Li, C. Bolm, Angew. Chem. Int. Ed. 2018, 57, 15602; Angew.
Chem. 2018; 130, 15828.
[12] J. Wen, H. Cheng, S. Dong, C. Bolm, Chem. Eur. J. 2016, 22, 5547.
[13] a) P. K. Chinthakindi, A. Benediktsdottir, A. Ibrahim, A. Wared, C.-J.
Aurell, A. Pettersen, E. Zamaratski, P. I. Arvidsson, Y. Chen, A.
Sandström, Eur. J. Org. Chem. 2019, 2019, 1045. b) S. V. Zasukha, V.
M. Timoshenko, A. A. Tolmachev, V. O. Pivnytska, O. Gavrylenko, S.
Zhersh, Y. Shermolovich, O. O. Grygorenko, Chem. Eur. J. 2019, 25,
6928.
Acknowledgements
We gratefully acknowledge The Royal Society [University
Research Fellowship, UF140161 (to J. A. B.) and URF appointed
grant RG150444, and URF enhancement grant, RGF\EA\180031],
and EPSRC [CAF to J.A.B. (EP/J001538/1), Impact Acceleration
Account (EP/K503733/1), DTA Studentship (to E.L.B.)]. This
research was supported by the project MISE, Horizon 2020 –
PON 2014/2020 FARMIDIAB “code 338”, the University of Bari.
[14] M. Zenzola, R. Doran, L. Degennaro, R. Luisi, J. A. Bull, Angew. Chem.
Int. Ed. 2016, 55, 7203; Angew. Chem. 2016, 128, 7319.
[15] F. Izzo, M. Schäfer, R. Stockman, U. Lücking, Chem. Eur. J. 2017, 23,
15189.
[16] A. Tota, M. Zenzola, S. J. Chawner, S. St John-Campbell, C. Carlucci, G.
Romanazzi, L. Degennaro, J. A. Bull, R. Luisi, Chem. Commun. 2017,
53, 348.
[17] For related reports at a similar time, see: a) J.-F. Lohier, T. Glachet, H.
Marzag, A.-C. Gaumont, V. Reboul, Chem. Commun. 2017, 53, 2064; b)
Y. Xie, B. Zhou, S. Zhou, S. Zhou, W. Wei, J. Liu, Y. Zhan, D. Cheng, M.
Chen, Y. Li, et al., ChemistrySelect 2017, 2, 1620; Also see: c) S.
Keywords: hypervalent iodine • reactive intermediates • sulfur •
sulfonimidamides • synthetic methods
This article is protected by copyright. All rights reserved.